- AMGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $409.6 million.
- AMGN is up 2.8% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AMGN with the Ticky from Trade-Ideas. See the FREE profile for AMGN NOW at Trade-Ideas More details on AMGN: Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. The stock currently has a dividend yield of 2%. AMGN has a PE ratio of 19.9. Currently there are 7 analysts that rate Amgen a buy, no analysts rate it a sell, and 9 rate it a hold. The average volume for Amgen has been 3.0 million shares per day over the past 30 days. Amgen has a market cap of $93.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.37 and a short float of 1.3% with 2.59 days to cover. Shares are up 7.5% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.